Work

Abstract PR006: Initial results of a cohort of advanced pancreatic cancer patients in a phase 1b Study of NGM120, a first-in-class anti-GDNF Family Receptor Alpha Like (GFRAL) antibody

Year: 2022

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.panca22-pr006

Authors: Andrew Hendifar, Efrat Dotan, Benjamin Weinberg, Edward Kim, Peter Hosein, Jian Luo, Jiping Zha, Alex DePaoli, Vladimir Hanes, Cecilia Tranmuchowski, Kefei Zhou, Carol Tseng, Hsiao Lieu

Institutions: Cedars-Sinai Medical Center, Fox Chase Cancer Center, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, University of California, Davis, University of Miami, Sylvester Comprehensive Cancer Center, NGM Biopharmaceuticals (United States)

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4309185778

Cites:

Cited by: 3

Related to: 10